ZINC Drug Patent Profile
✉ Email this page to a colleague
When do Zinc patents expire, and when can generic versions of Zinc launch?
Zinc is a drug marketed by Pharmafair, Exela Pharma, Hospira, Abraxis Pharm, Am Regent, Fresenius Kabi Usa, Gland Pharma Ltd, and Zydus Pharms. and is included in eight NDAs.
The generic ingredient in ZINC is zinc sulfate. There are thirty-eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the zinc sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zinc
A generic version of ZINC was approved as zinc sulfate by AM REGENT on July 18th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZINC?
- What are the global sales for ZINC?
- What is Average Wholesale Price for ZINC?
Summary for ZINC
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Drug Prices: | Drug price information for ZINC |
| Drug Sales Revenues: | Drug sales revenues for ZINC |
| What excipients (inactive ingredients) are in ZINC? | ZINC excipients list |
| DailyMed Link: | ZINC at DailyMed |
US Patents and Regulatory Information for ZINC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmafair | ZINC BACITRACIN,NEOMYCIN SULFATE,POLYMYXIN B SULFATE & HYDROCORTISONE | bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 062389-001 | Jul 2, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Am Regent | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 209377-001 | Jul 18, 2019 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Abraxis Pharm | ZINC SULFATE | zinc sulfate | INJECTABLE;INJECTION | 019229-002 | May 5, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Gland Pharma Ltd | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 216249-001 | May 3, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 216145-001 | Dec 27, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Zydus Pharms | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 217074-002 | Aug 22, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Zydus Pharms | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 217074-003 | Aug 22, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
